Multiply Labs Pitch Deck

Based in ​San Francisco, Multiply Labs develops robotic systems for pharmaceutical manufacturing. These robotic systems automates manual processes involved in producing cell and gene therapies and other biologic medicines.

The company was started as a nutritional supplement company by a PhD student at MIT, Fred Parietti. It later expanded into cell therapy manufacturing and developed partnerships with well-known companies including NVIDIA, Retro Biosciences, AstraZeneca, Legend Biotech, Kyverna Therapeutics, Universal Robots, and others.

In Oct 2026, Multiply Labs announced that it has raised a $75 million Series B round, bringing its total capital raised to over $100 million. The round was led by Dr. Patrick Soon-Shiong with NantWorks, with new investors AstraZeneca, Lingotto, Teradyne, and Strange Ventures, and returning investors Casdin Capital, Lux Capital, Fifty Years, Ora Global, and Founders Fund, among others.

$75M • 2026 • Series B